Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Buy
219,319
+19,800
+10% +$353K 6.17% 8
2026
Q1
$3.8M Buy
199,519
+12,445
+7% +$240K 6.67% 7
2025
Q4
$3.06M Buy
187,074
+70,147
+60% +$1.23M 5.67% 8
2025
Q3
$2.2M Buy
+116,927
New +$2.1M 4.05% 9
2024
Q4
Sell
-37,807
Closed -$678K 51
2024
Q3
$678K Buy
+37,807
New +$689K 0.77% 23

Other funds holding XP

Oaktree Fund Advisors's XP Position: Q2 2026 in Review

Oaktree Fund Advisors increased its XP (XP) stake by 9.9% in Q2 2026, buying an estimated $353K and bringing the position to 219,319 shares worth $3.57M. The position accounts for 6.17% of the portfolio, ranked #8.

Oaktree Fund Advisors first reported a position in XP in Q3 2024 and has held it in 5 quarters since. The position peaked at $3.8M in Q1 2026. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Oaktree Fund Advisors held 219,319 shares of XP worth $3.57M as of Q2 2026.
  • Oaktree Fund Advisors bought 19,800 XP shares in Q2 2026, an estimated $353K.
  • XP made up 6.17% of Oaktree Fund Advisors's portfolio in Q2 2026, its #8 holding.
  • Oaktree Fund Advisors first reported a position in XP in Q3 2024 and has held it in 5 quarters since.
  • Oaktree Fund Advisors's XP position peaked at $3.8M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Oaktree Fund Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.